statistiche ricercatore

Nazione	#
RU - Federazione Russa	438
US - Stati Uniti d'America	377
SG - Singapore	166
BR - Brasile	106
CN - Cina	79
HK - Hong Kong	51
IE - Irlanda	43
VN - Vietnam	33
SE - Svezia	30
DE - Germania	18
GB - Regno Unito	14
FR - Francia	13
IT - Italia	13
IN - India	10
FI - Finlandia	9
AR - Argentina	7
BD - Bangladesh	7
PK - Pakistan	7
TR - Turchia	7
NL - Olanda	6
ZA - Sudafrica	5
CA - Canada	4
AL - Albania	3
BE - Belgio	3
CL - Cile	3
ES - Italia	3
JP - Giappone	3
KG - Kirghizistan	3
MX - Messico	3
PL - Polonia	3
AT - Austria	2
AU - Australia	2
BO - Bolivia	2
CZ - Repubblica Ceca	2
EC - Ecuador	2
IQ - Iraq	2
LB - Libano	2
PY - Paraguay	2
UZ - Uzbekistan	2
AZ - Azerbaigian	1
BY - Bielorussia	1
CO - Colombia	1
CY - Cipro	1
EG - Egitto	1
GE - Georgia	1
GT - Guatemala	1
IL - Israele	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
MA - Marocco	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
QA - Qatar	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TO - Tonga	1
TV - Tuvalu	1
Totale	1.507

Nome	#
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors	191
Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis	152
From autoinflammation to autoimmunity: old and recent findings	116
One year in review 2019: fibromyalgia	113
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study	106
Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review	104
Study of entheses in patients with spondyloarthritis and inflammatory bowel disease with and without fibromyalgia: The importance of ultrasonography	92
Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases	88
The effect of drugs used in rheumatology for treating SARS-CoV2 infection	88
Concerns about the safety of anti-TNF agents when treating rheumatic diseases	85
Toxicological considerations in the treatment of axial spondylo-arthritis	74
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis	69
One year in review 2021: fibromyalgia	69
The rheumatology drugs for COVID-19 management: Which and when?	65
Behçet disease: From pathogenesis to novel therapeutic options	64
Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab	56
Totale	1.532

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	3	0	0	0	0	0	0	0	0	0	1	2	0
2021/2022	38	0	2	0	1	0	0	3	2	0	9	1	20
2022/2023	130	9	10	11	10	10	10	1	10	53	1	3	2
2023/2024	65	2	4	10	4	8	34	0	0	0	2	0	1
2024/2025	354	8	3	3	22	5	21	21	58	71	31	48	63
2025/2026	885	37	60	49	56	84	223	108	123	100	45	0	0
Totale													1.532